Fracture News and Research

RSS

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

The way that clinicians report outcomes of surgery for a traumatic nerve injury involving the arm is not standardized, and it is thus difficult to compare the efficacy of different surgical treatments, according to a study by researchers at Hospital for Special Surgery (HSS) in New York.

20 May 2011

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended a positive opinion for the marketing authorization of XGEVA (denosumab) for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumors.

20 May 2011

$Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment$

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

Medtronic, Inc. today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate bone cement for use in the treatment of spinal fractures with minimally invasive Kyphon Balloon Kyphoplasty.

From Medtronic 17 May 2011

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Using geriatric mice, a Johns Hopkins research team has shown that losartan, a commonly used blood pressure drug, not only improves regeneration of injured muscle but also protects against its wasting away from inactivity.

12 May 2011

$Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis$

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

One in 10 heart failure patients had compression fractures in the spine that could have been detected by a chest X-ray, but few are receiving treatment to help prevent such fractures according to a Canadian study published in the American Heart Association journal Circulation: Heart Failure.

11 May 2011

IOF launches Vertebral Fracture Initiative for health professionals

Vertebral fractures are a common cause of pain and disability - and they are also powerful predictors of future spine and hip fractures. Yet there is evidence that many health professionals simply fail to recognize vertebral fractures in their patients. Even if the fractures are reported, appropriate intervention is often not initiated.

10 May 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

Unigene first quarter net loss decreases 58% to $6.6 million

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced first quarter financial results for the period ended March 31, 2011. The Company highlighted significant progress achieved in the first quarter with the execution of its turnaround strategy.

9 May 2011

FDA approves Medtronic's two new dual-electrode leads for cardiac resynchronization therapy devices

Medtronic, Inc. today announced the U.S. Food and Drug Administration approval and launch of the Attain Ability Plus and the Attain Ability Straight left-heart leads for use with cardiac resynchronization therapy devices in treating heart failure patients.

From Medtronic 6 May 2011

$Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study$

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

According to a new study, nearly 78% of all Swedish women aged 55 years and older who sustained a thigh bone or femur fracture in 2008 had taken bisphosphonates for their osteoporosis. However the authors of the study published in the May 5 issue of the New England Journal of Medicine (NEJM) write that the absolute risk for such breaks is small enough to justify prescribing the drugs.

5 May 2011

$Study: Bisphosphonates can cause fatigue fractures$

Study: Bisphosphonates can cause fatigue fractures

Bisphosphonates are a medication that has been administered since the 1990s, which reduces the overall risk of brittleness and incidence of osteoporosis. Bisphosphonates deactivate those cells used to break down bone and therefore prevent fractures caused by brittleness of the bone.

5 May 2011

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

Has a bone density scan placed you at risk for osteoporosis, leading your doctor to prescribe a widely advertised bone-building medication? Not so fast! A University of Illinois study finds that an effective first course of action is increasing dietary calcium and vitamin D or taking calcium and vitamin D supplements.

3 May 2011

Study finds disparities in male, female patients for heart disease treatment at U.S. hospitals

A study released today by HealthGrades, the nation's leading, independent source of physician information and hospital quality ratings, found notable disparities in the treatment and outcomes of male and female patients at U.S. hospitals.

3 May 2011

$Hyponatremia linked to high risk of fractures in elderly patients$

Hyponatremia linked to high risk of fractures in elderly patients

A common blood disorder, hyponatremia, may be a risk factor for fractures in elderly patients, new research presented at the European Congress of Endocrinology shows.

3 May 2011

Investigators to advance research and care of the elderly

The demographics are dauanting: between 2005 and 2030, the number of adults 65 and over in the United States is expected to nearly double.

2 May 2011

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

IOF and the ANZBMS, together with the Japanese Bone and Mineral Research Society, invite researchers and clinicians with an interest in osteoporosis and bone research to attend the year's most important bone meeting in the Asia-Pacific region.

29 Apr 2011

SI-BONE receives FDA approval for updated iFuse Implant System

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint announced the U.S. Food and Drug Administration approved a major modification to the existing product label.

26 Apr 2011

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Daiichi Sankyo Company, Limited, announced today that the company has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets, by the Ministry of Health, Labor and Welfare in Japan.

22 Apr 2011

Study identifies major osteoporosis knowledge gaps for some patient groups

A fracture in a person over the age of 50 can be a sign of osteoporosis, yet some patient populations have little knowledge of the disease. According to a groundbreaking study published in a recent Journal of Bone and Joint Surgery (JBJS), male and non-English speaking patients tend to have the least knowledge of osteoporosis, putting them at high risk for a subsequent fracture.

22 Apr 2011

Amgen, UCB report positive results from AMG 785/CDP7851 comparative Phase 2 study for postmenopausal osteoporosis

Amgen and UCB announced today positive top-line results from their Phase 2 clinical study comparing sclerostin-antibody AMG 785/CDP7851 to placebo in postmenopausal women with low bone mineral density (BMD) for the treatment of postmenopausal osteoporosis (PMO).

21 Apr 2011

Fracture News and Research

HSS researchers develop new tool to compare efficacy of different brachial plexus surgical treatments

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

Medtronic announces U.S. launch of Kyphon Xpede Bone Cement for spinal fracture treatment

Losartan therapy improves muscle injury regeneration and prevents disuse atrophy

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

IOF launches Vertebral Fracture Initiative for health professionals

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Unigene first quarter net loss decreases 58% to $6.6 million

FDA approves Medtronic's two new dual-electrode leads for cardiac resynchronization therapy devices

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

Study: Bisphosphonates can cause fatigue fractures

Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis

Study finds disparities in male, female patients for heart disease treatment at U.S. hospitals

Hyponatremia linked to high risk of fractures in elderly patients

Investigators to advance research and care of the elderly

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

SI-BONE receives FDA approval for updated iFuse Implant System

Daiichi Sankyo's LIXIANA receives Japanese marketing approval

Study identifies major osteoporosis knowledge gaps for some patient groups

Amgen, UCB report positive results from AMG 785/CDP7851 comparative Phase 2 study for postmenopausal osteoporosis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News